Recurrent, Delayed Hemorrhage Associated with Edoxaban after Deep Brain Stimulation Lead Placement
Factor-Xa inhibitors like edoxaban have been shown to have comparable or superior rates of stroke and systemic embolization prevention to warfarin while exhibiting lower clinically significant bleeding rates. The authors report a case of a man who presented with delayed, recurrent intracranial hemor...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wiley
2013-01-01
|
| Серии: | Case Reports in Neurological Medicine |
| Online-ссылка: | http://dx.doi.org/10.1155/2013/691840 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|